Study of CD38 and CD56 in Chronic Myeloid Leukemia
ConditionChronic Myeloid Leukemia (CML)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSohag University
About this trial
Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.
The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.
Eligibility criteria
Qualifiers
patients with chronic myeloid leukemia
Disqualifiers
other hematological diseases
Trial design
Treatments tested in this trial
- cd 38 and cd 56
Treatment groups
200 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov